On May 8, 2023, tumor biopsy samples from patients were subjected to whole-exome sequencing (WES), and the results revealed that the expression level of programmed death receptor ligand (PD-L1) protein was TPS (Tumor Proportion Score) = 10%, CPS (Combined Positive Score) = 10 (Detection Atlas see Figure 5). The gene discussed is CD274; the disease is neoplasm.